Healthcare provider profile · identity verified

Heidi E Heffner

Nurse Practitioner · HORSHAM, PA · NPI 1093234403

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Mirtazapine	Mirtazapine	440	14
Sertraline Hcl	Sertraline Hcl	423	13
Divalproex Sodium	Divalproex Sodium	303	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	195	suppressed
Losartan Potassium	Losartan Potassium	183	suppressed
Furosemide	Furosemide	181	11
Quetiapine Fumarate	Quetiapine Fumarate	164	11
Lisinopril	Lisinopril	151	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	137	suppressed
Trazodone Hcl	Trazodone Hcl	136	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	120	suppressed
Haloperidol	Haloperidol	118	suppressed
Risperidone	Risperidone	108	suppressed
Amlodipine Besylate	Amlodipine Besylate	105	suppressed
Bupropion Xl	Bupropion Hcl	104	suppressed
Buspirone Hcl	Buspirone Hcl	102	suppressed
Metoprolol Succinate	Metoprolol Succinate	101	suppressed
Atorvastatin Calcium	Atorvastatin Calcium	99	suppressed
Oxcarbazepine	Oxcarbazepine	95	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	91	suppressed
Olanzapine	Olanzapine	91	suppressed
Omeprazole	Omeprazole	87	suppressed
Potassium Chloride	Potassium Chloride	87	suppressed
Divalproex Sodium Er	Divalproex Sodium	80	suppressed
Xtampza Er	Oxycodone Myristate	74	suppressed
Eliquis	Apixaban	73	suppressed
Ropinirole Hcl	Ropinirole Hcl	69	suppressed
Donepezil Hcl	Donepezil Hcl	67	suppressed
Gabapentin	Gabapentin	67	suppressed
Tramadol Hcl	Tramadol Hcl	57	11
Paroxetine Hcl	Paroxetine Hcl	56	suppressed
Levetiracetam	Levetiracetam	55	suppressed
Lorazepam	Lorazepam	54	14
Atenolol	Atenolol	52	suppressed
Entresto	Sacubitril/Valsartan	52	suppressed
Jardiance	Empagliflozin	52	suppressed
Lamotrigine	Lamotrigine	52	suppressed
Memantine Hcl Er	Memantine Hcl	52	suppressed
Xarelto	Rivaroxaban	52	suppressed
Allopurinol	Allopurinol	51	suppressed
Clopidogrel	Clopidogrel Bisulfate	51	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	50	suppressed
Clonazepam	Clonazepam	49	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	46	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	44	suppressed
Montelukast Sodium	Montelukast Sodium	43	suppressed
Baclofen	Baclofen	40	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	suppressed
Amiodarone Hcl	Amiodarone Hcl	39	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Myrbetriq	Mirabegron	37	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	35	35
Dicyclomine Hcl	Dicyclomine Hcl	32	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	32	suppressed
Spironolactone	Spironolactone	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Torsemide	Torsemide	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Ozempic	Semaglutide	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Midodrine Hcl	Midodrine Hcl	25	suppressed
Carvedilol	Carvedilol	23	suppressed
Risperidone Er	Risperidone Microspheres	23	suppressed
Anastrozole	Anastrozole	22	suppressed
Metformin Hcl	Metformin Hcl	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Methenamine Hippurate	Methenamine Hippurate	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Morphine Sulfate	Morphine Sulfate	15	13
Ondansetron Hcl	Ondansetron Hcl	15	11
Premarin	Estrogens, Conjugated	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Konvomep	Omeprazole/Sodium Bicarbonate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	12	suppressed
Prednisone	Prednisone	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error